Literature DB >> 8177472

Effect of cyclosporin on kidney proteolytic enzymes in men and rats.

C J Olbricht1, M Steinker, W Auch-Schwelk, C Bossaller, J Haas, K M Koch.   

Abstract

Cyclosporin (CsA) induces autophagolysosomes in proximal tubules. A major lysosomal function is degradation of cell proteins. Cathepsin B and L are marker enzymes for the activity of lysosomal protein degradation. Therefore we measured cathepsin activities in microdissected proximal tubule segments and urine from rats treated with CsA, 30 mg/24 h by gavage for 42 days. Cathepsin activity was increased in proximal tubule by 117% and in 24-h urine by 37% compared to controls. Unchanged values of serum cathepsin activity and of proteinuria excluded increased glomerular filtration or decreased tubular absorption as major source of urine cathepsins. Therefore urine cathepsin excretion reflected tubular cathepsin activity. Urine cathepsin excretion was also measured in patients without renal disease treated with CsA for multiple sclerosis (MS). It was increased by 59% in patients with CsA serum values > 120 ng/ml compared to MS patients without CsA or with serum CsA < 120 ng/ml. Urine cathepsin excretion increased linearly with serum CsA (P < 0.001). The data suggest that cathepsin activity is increased in proximal tubules of CsA-treated patients. Hence CsA may stimulate protein degradation in proximal tubules of men and rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8177472

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  2 in total

1.  Cyclosporine A induced histological changes of Cathepsin L and CD2AP expression in renal glomeruli and tubules.

Authors:  Keisuke Sugimoto; Tomoki Miyazawa; Takuji Enya; Kouhei Miyazaki; Mitsuru Okada; Tsukasa Takemura
Journal:  Clin Exp Nephrol       Date:  2016-03-14       Impact factor: 2.801

2.  Systems biology modeling of omics data: effect of cyclosporine a on the Nrf2 pathway in human renal cells.

Authors:  Jérémy Hamon; Paul Jennings; Frederic Y Bois
Journal:  BMC Syst Biol       Date:  2014-06-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.